Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.283, 2000-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Which gemcitabine dosage schedule best in NSCLC?
Inpharma, Vol. 1, Iss. 1479, 2005-01 ,pp. :
Access to resources
Recommend
Time to consider placebo effect in QOL studies in NSCLC?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 327, 2001-01 ,pp. :
RRM1-based tailored chemotherapy for NSCLC?
Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. :
Polymorphisms: prognostic factors in advanced NSCLC?
Inpharma, Vol. 1, Iss. 1454, 2004-01 ,pp. :
Gemcitabine + vinorelbine: superior to platinum-based regimens in NSCLC?
Inpharma, Vol. 1, Iss. 1308, 2001-01 ,pp. :